P072 MESENCHYMAL STEM CELLS AMELIORATE DSS-INDUCED CHRONIC COLITIS IN MICE BY INDUCING PHENOTYPIC CHANGES OF DENDRITIC CELLS.

Mesenchymal stem cells (MSCs), which are an emerging cell therapeutic for inflammatory bowel disease (IBD), have demonstrated immunomodulatory effects through interactions with T cells and dendritic cells (DCs).